Jun 03, 2026
13:10
For every 10 shares held, investors received 13. The price per share adjusted from $18.78 to $14.45.
The split itself did not change the total investment value.
Nanjing Vazyme Biotech Co., Ltd. Class A (SSE:688105) operates in the Biotechnology industry.
Nanjing Vazyme Biotech Co., Ltd. Class A company overviewNanjing Vazyme Biotech Co., Ltd. Class A's most recent stock split was on June 3, 2026. It was a 13-for-10 forward split, so shareholders received 13 shares for every 10 they held.
Nanjing Vazyme Biotech Co., Ltd. Class A has split its stock once. This history records one forward split, on June 3, 2026.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Nanjing Vazyme Biotech Co., Ltd. Class A's 13-for-10 split on June 3, 2026, every 10 shares became 13 shares.
Nanjing Vazyme Biotech Co., Ltd. Class A has not announced a new split in our records. Its most recent split was on June 3, 2026, less than a year ago. Companies announce splits in advance, and any new SSE:688105 split will appear on this page.
Already premium?